Clinical Trial Update: Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial is evaluating cytokine-induced killer (CIK) cells for treating stage I-II malignant gliomas; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: The First People's Hospital of Changzhou | Conditions: Cytokine-Induced Killer Cells, Milignant Gliomas | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING